Despite advances in the understanding of the underlying mechanisms of AD, no effective disease modifying therapy exists
The 25-mg/kg dose reduced these parameters by 48.8%, 30.3%, 33.4%, and 47.5%, respectively, while the 50-mg/kg dose showed more pronounced effects, reducing them by 67.9%, 58.6%, 60.4%, and 73.6%, respectively, in comparison with the TAA group (Figures 4AD)
With proper sterile technique, you can continue sampling from the same vial for 3+ months the standard "discard after 28 days" disclaimer is an FDA bacteriostatic labeling requirement, not a reflection of peptide efficacy
And unlike many analgesics, the improvements appear to reflect actual healing rather than just symptom suppression